<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR33">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kumar</surname>
    <given-names>SK</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Treatment outcomes, health-care resource utilization and costs of bortezomib and dexamethasone, with cyclophosphamide or lenalidomide, in newly diagnosed multiple myeloma</article-title>
  <source>Leukemia</source>
  <year>2016</year>
  <volume>30</volume>
  <fpage>995</fpage>
  <lpage>998</lpage>
  <pub-id pub-id-type="doi">10.1038/leu.2015.225</pub-id>
  <?supplied-pmid 26271606?>
  <pub-id pub-id-type="pmid">26271606</pub-id>
 </element-citation>
</ref>
